November 22, 2021
The Pharmaceuticals and Medical Devices Agency (PMDA) on November 19 announced a label update for Mylan EPD’s Amitiza (lubiprostone) for the addition of positive clinical trial data on its use in opioid-induced constipation. In the previous label, it was noted...read more